Literature DB >> 11519385

Gilbert's syndrome--clinical and pharmacological implications.

P Radu1, J Atsmon.   

Abstract

Mesh:

Substances:

Year:  2001        PMID: 11519385

Source DB:  PubMed          Journal:  Isr Med Assoc J            Impact factor:   0.892


× No keyword cloud information.
  12 in total

1.  Are liver function tests, pancreatitis and cholecystitis predictors of common bile duct stones? Results of a prospective, population-based, cohort study of 1171 patients undergoing cholecystectomy.

Authors:  Per Videhult; Gabriel Sandblom; Claes Rudberg; Ib Christian Rasmussen
Journal:  HPB (Oxford)       Date:  2011-05-11       Impact factor: 3.647

2.  Successful operation for mitral regurgitation in a patient with Gilbert's syndrome.

Authors:  Hiroya Minami; Tatsuro Asada; Kunio Gan; Akitoshi Yamada; Yoshihiko Yano
Journal:  Gen Thorac Cardiovasc Surg       Date:  2011-05-06

3.  Perioperative management of a patient with Gilberts syndrome and rheumatic heart disease.

Authors:  R V Ranjan; T R Ramachandran; David George Veliath; Diana Coelho
Journal:  Saudi J Anaesth       Date:  2012-07

4.  General anesthesia in a patient with Gilbert's syndrome.

Authors:  Deb Sanjay Nag; Niraj Sinha; Devi Prasad Samaddar; Pratap Rudra Mahanty
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2011-04

5.  Severe jaundice in two children with Kawasaki disease: a possible association with Gilbert syndrome.

Authors:  Themistocles Karpathios; Maria Moustaki; Panagiotis Yiallouros; Fariba Sharifi; Achilleas Attilakos; Anna Papadopoulou; Andrew Fretzayas
Journal:  J Korean Med Sci       Date:  2011-12-19       Impact factor: 2.153

6.  Longer telomeres in chronic, moderate, unconjugated hyperbilirubinaemia: insights from a human study on Gilbert's Syndrome.

Authors:  Anela Tosevska; Christine Moelzer; Marlies Wallner; Milan Janosec; Ursula Schwarz; Carina Kern; Rodrig Marculescu; Daniel Doberer; Wolfram Weckwerth; Karl-Heinz Wagner
Journal:  Sci Rep       Date:  2016-03-01       Impact factor: 4.379

7.  Characteristics of the heme catabolic pathway in mild unconjugated hyperbilirubinemia and their associations with inflammation and disease prevention.

Authors:  Christine Mölzer; Marlies Wallner; Carina Kern; Anela Tosevska; René Zadnikar; Daniel Doberer; Rodrig Marculescu; Karl-Heinz Wagner
Journal:  Sci Rep       Date:  2017-04-07       Impact factor: 4.379

8.  UGT1A1 (TA)n Promoter Genotype: Diagnostic and Population Pharmacogenetic Marker in Serbia.

Authors:  M Vukovic; N Radlovic; Z Lekovic; K Vucicevic; N Maric; N Kotur; V Gasic; M Ugrin; M Stojiljkovic; L Dokmanovic; B Zukic; S Pavlovic
Journal:  Balkan J Med Genet       Date:  2018-10-29       Impact factor: 0.519

9.  Features of an altered AMPK metabolic pathway in Gilbert's Syndrome, and its role in metabolic health.

Authors:  Christine Mölzer; Marlies Wallner; Carina Kern; Anela Tosevska; Ursula Schwarz; Rene Zadnikar; Daniel Doberer; Rodrig Marculescu; Karl-Heinz Wagner
Journal:  Sci Rep       Date:  2016-07-21       Impact factor: 4.379

10.  Utility of liver function tests in acute cholecystitis.

Authors:  Hady Zgheib; Cynthia Wakil; Sami Shayya; Aurelie Mailhac; Muhyeddine Al-Taki; Mazen El Sayed; Hani Tamim
Journal:  Ann Hepatobiliary Pancreat Surg       Date:  2019-08-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.